- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05859568
Baseline Performance and Fitting Parameters for Sonova Products
May 8, 2025 updated by: Advanced Bionics
The purpose of this study is to assess the effectiveness and optimization of various FDA approved products.
Study Overview
Status
Enrolling by invitation
Intervention / Treatment
Detailed Description
This study uses a prospective within-subjects repeated-measures design in which each subject serves as her/his own control.
The purpose of this study is to assess the effectiveness and optimization of various FDA approved hardware, signal preprocessing and processing software, fitting characteristics, and service delivery methods, such as remote support and/or tele-audiology on an expanded subject demographic.
The insights gained from this study will be used to optimize listening configuration recommendations, refine audiological practice, and inform future innovations.
Study Type
Interventional
Enrollment (Estimated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Valencia, California, United States, 91355
- Advanced Bionics
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Ability to provide Informed Consent/Assent
Adults (age +18 years) and children (8-17 years) can be enrolled in this study
- If child is aged 8-17 years, an assent will be completed, and the subject must be accompanied by a parent or legal guardian for all study activities
- Have the functional capability to operate the controls for the device and to comply with all directions during the study as determined by the investigator conducting the consent/baseline visit
- English language proficiency as determined by the investigator
Exclusion Criteria:
• Have any significant medical condition that, in the opinion of any of the investigators, is likely to interfere with study procedures or likely to confound evaluation of study endpoints
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Microphone Location versus Microphone Algorithm Comparison
Comparing performance and subjective feedback for pinna-located microphone versus a pinna-simulated microphone algorithm.
|
Sound processors using a pinna-located microphone
Sound processors using a pinna-simulated algorithm
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Speech performance in noise
Time Frame: 1 day
|
The primary efficacy endpoint is recorded AzBio sentences presented from a single loud speaker at 60 dBA.
The recognition scores using the pinna-located microphone in quiet and noise captured at initial visit will be compared to the AzBio sentence recognition scores using the pinna-simulated microphone.
Scores are determined on a scale of 0% to 100% words correct with higher scores indicating a better outcome.
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Localization performance
Time Frame: 1 day
|
A secondary efficacy endpoint is a front/back localization task where filtered pink noise is presented at 60dBA from one of six speakers in a 360 degree array.
Scores are generated in percent correct; the scores obtained from the pinna-located microphone will be compared to the localization scores using the pinna-simulated microphone.
|
1 day
|
|
Analysis of usability and preference questionnaire
Time Frame: 8 weeks
|
Subject responses captured on a usability and preference questionnaire at the initial visit will be compared to responses on the questionnaire administered after each two-week chronic use interval.
Questions will inquire about subject's ability and experience hearing and listening in different situations and wearing configuration preferences.
The questions are rated on a 5-point Likert scale with varying strength, such as "It was easy to verify proper microphone function" with answers ranging from strongly disagree to strongly agree.
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 17, 2023
Primary Completion (Estimated)
April 17, 2028
Study Completion (Estimated)
April 17, 2028
Study Registration Dates
First Submitted
May 5, 2023
First Submitted That Met QC Criteria
May 5, 2023
First Posted (Actual)
May 16, 2023
Study Record Updates
Last Update Posted (Actual)
May 13, 2025
Last Update Submitted That Met QC Criteria
May 8, 2025
Last Verified
May 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CPR2301
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ear Diseases
-
University of ArkansasWithdrawn
-
Kaplan Medical CenterUnknown
-
Simbec ResearchSensorion SACompletedInner Ear Diseases
-
Nitinetics LLCRecruitingMiddle Ear DiseaseUnited States
-
Northwell HealthRecruitingEar Diseases | Middle Ear Disease | Pressure Injury | Eustachian Tube Dysfunction | Ear Barotrauma | Middle Ear; Injury | Middle Ear BarotraumaUnited States
-
Northwell HealthCompletedMiddle Ear Disease | Pressure Injury | Eustachian Tube Dysfunction | Ear Barotrauma | Middle Ear; Injury | Middle Ear BarotraumaUnited States
-
Fondation Ophtalmologique Adolphe de RothschildCompleted
-
Cuneyt M. AlperNational Institute on Deafness and Other Communication Disorders (NIDCD)Completed
-
TC Erciyes UniversityCompletedMiddle Ear DiseaseTurkey (Türkiye)
-
Simbec ResearchSensorionCompleted
Clinical Trials on Pinna-located microphone
-
Sonova AGHearts for HearingCompleted
-
Emory UniversityRecruiting
-
Loyola UniversityActive, not recruitingNon Small Cell Lung CancerUnited States
-
Sonova AGSonova Canada Inc.Completed
-
Ligue Pulmonaire NeuchâteloiseNot yet recruitingChronic Obstructive Pulmonary Disease | Respiratory DiseaseSwitzerland
-
Sonova AGCompleted
-
University of FloridaCompletedNon-Small Cell Lung CancerUnited States
-
University of California, Los AngelesUniversity of Rochester; Agency for Healthcare Research and Quality (AHRQ)CompletedChildhood Influenza Vaccination | School-located Influenza Vaccination
-
SMG-SNU Boramae Medical CenterNot yet recruitingTechnique for Locating the Cricoid Cartilage
-
Insel Gruppe AG, University Hospital BernRecruitingLaryngopharyngeal Reflux Disease | GERD Gastroesophageal Reflux DiseaseSwitzerland